The FDA recently issued a warning about a serious complication of certain medications for diabetes popular .
gliptins, known as inhibitors of DPP-4, includes drugs like Januvia and Onglyza . Januvia was approved by the FDA in 2006 and reached pharmacy shelves Onglyza in 2009. The drugs are used to control blood sugar
severe joint pain :.
Now, after several years, the agency has determined that these and other medications can cause potentially disabling and severe joint pain. The pain may begin within a few days of starting the medication, but some people report that can take years to appear. In most cases it disappears after one month of stopping the medication.
The FDA encourages people to report any pain in the joints of his prescribers promptly. It also recommended the suspension of the drug without medical supervision.
was detected This side effect through case reports that doctors performed in FDA MedWatch progra m with respect to joint pain as a side effect is suspected that these drugs diabetes. The agency encourages health professionals to continue to report serious adverse events to MedWatch. The patient may also report unexpected or serious reactions
Other side effects :.
These drugs can cause other side effects. The most worrisome involve inflammation of the pancreas and pancreatic cancer, possibly. You can read more about here .